Journals / Retina-Vitreus / 2019 / Cilt: 28 - Sayı: 2

Pupil Diameter Study: Factors Effecting Pupil Size In Diabetic Patients

Pupil Çapı Çalışması: Diyabetik Hastalarda Pupil Çapını Etkileyen Etmenler

Pages
117–121
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, pan-retinal photocoagulation and the number of intravitreal injections were insignifi cantly related to the pupillary diameter.Conclusion: Among the factors studied, the severity and duration of diabetes were the prominent factors that played important roles in affecting the pupillary diameter in the diabetic patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study was designed to assess the factors affecting the pupillary diameter in patients with diabetic retinopathy.Materials and Methods: One hundred and eight eyes of fi fty-four patients were evaluated cross-sectionally to study the factors affecting thepupillary diameter in diabetic patients.
📊
Key Findings & Data:The pupillary diameter was measured using a Pentacam 30 min after the cyclopentolate administration.The severity and duration of diabetes, phakic or intraocular lens status, pan-retinal photocoagulation history, α1A-blocker use, intravitreal injection, and vitrectomy history were the items included in this study that could affect the pupillary diameter.
💡
Conclusion & Impact:Moreover, pan-retinal photocoagulation and the number of intravitreal injections were insignifi cantly related to the pupillary diameter.Conclusion: Among the factors studied, the severity and duration of diabetes were the prominent factors that played important roles in affecting the pupillary diameter in the diabetic patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: This study was designed to assess the factors affecting the pupillary diameter in patients with diabetic retinopathy.Materials and Methods: One hundred and eight eyes of fi fty-four patients were evaluated cross-sectionally to study the factors affecting thepupillary diameter in diabetic patients. The pupillary diameter was measured using a Pentacam 30 min after the cyclopentolate administration.The severity and duration of diabetes, phakic or intraocular lens status, pan-retinal photocoagulation history, α1A-blocker use, intravitreal injection, and vitrectomy history were the items included in this study that could affect the pupillary diameter. The visual acuity and intraocularpressure were also assessed.Results: The outcomes of the present study revealed that the pupillary diameter was smaller in those patients with proliferative retinopathy andlong-term diabetes, and that the mean pupillary diameter was also smaller in the intraocular lens implanted patients. In addition, α1A-blockeruse and a vitrectomy surgery history were related to the pupil size. Moreover, pan-retinal photocoagulation and the number of intravitreal injections were insignifi cantly related to the pupillary diameter.Conclusion: Among the factors studied, the severity and duration of diabetes were the prominent factors that played important roles in affecting the pupillary diameter in the diabetic patients

Özet

Amaç: Bu çalışma diyabetik retinopatili hastalarda pupil çapına etki eden faktörleri değerlendirmek amacıyla dizayn edildi. Gereç ve Yöntem: Diyabetik hastalarda pupil çapını etkileyen faktörleri incelemek amacı ile elli dört hastanın 108 gözü kesitsel olarak değerlendirildi. Pupil çapı, siklopentonat uygulamasından 30 dakika sonra Pentacam ile ölçüldü. Diyabetin şiddeti ve süresi, fakik veya göz içi lens olma durumu, panretinal fotokoagülasyon, α1A-bloker kullanımı, intravitreal enjeksiyon ve vitrektomi pupil çapını etkileyebilecek etmenler olarak çalışmaya dahil edildi. Görme keskinliği ve göz içi basıncı da değerlendirildi. Bulgular: Çalışmamızın sonuçları, proliferatif retinopati ve uzun dönem diyabetli hastalarda pupil çapının daha küçük olduğunu ve intraoküler lens yerleştirilen hastalarda da pupil çapının ortalamasının daha küçük olduğunu ortaya koymuştur. α1A-bloker kullanımı ve vitrektomi cerrahisi de pupil çapında kayda değer öneme sahipti. Pan-retinal fotokoagülasyon ve intravitreal enjeksiyon sayısı pupil çapında önemsizdi. Sonuç: Çalışılan faktörler arasında, diyabetin şiddeti ve süresi diyabetik hastalarda pupil çapında önemli rol oynayan faktörlerden belirgin olanlarıydı.

🔖

Cite This Article

KURT, M. M., EVLİYAOĞLU, F., AKPOLAT, Ç., ELCİOĞLU, M. N. (2022). Pupil Diameter Study: Factors Effecting Pupil Size In Diabetic Patients. Retina-Vitreus, Cilt: 28 - Sayı: 2, 117–121. https://ajindex.com/articles/589087

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Habib SL, Rojna M. Diabetes and risk of cancer. ISRN Oncol. 2013;2013:583786
  2. Kwon HJ, Kim HY. A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. Korean J Ophthalmol. 2009;23(4):291-5
  3. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic m acular edema. Curr Diab Rep. 2012;12:346-54
  4. Yang Y., Yu Y., Yao K., “Pupillary dysfunction in Type 2 diabetes mellitus to refi ne the early diagnosis of diabetic autonomic neuropathy,” Neuro-Ophthalmology. 2006;30(1):17-21
  5. Bremner FD, Smith SE. Pupil abnormalities in selected autonomic neuropathies. J Neuroophthalmol. 2006;26:209-19
  6. Lei HL, Yang KJ, Sun CC, Chen CH, Huang BY, Ng SC, Yeung L. Obtained mydriasis in long-term type 2 diabetic patients. J Ocul Pharmacol Ther. 2011;27(6):599-602
  7. Cahill, M., Eustace, P., and de Jesus, V. Pupillary autonomic denervation with increasing duration of diabetes mellitus. Br. J. Ophthalmol. 2001;85:1225-30
  8. Pittasch D., Lobmann R., Behrens-Baumann W., Lehnert H., “Pupil signs of sympathetic autonomic neuropathy in patients with Type 1 diabetes,” Diabetes Care. 2002;25(9):1545-50
  9. Adnan X, Suheimat M, Efron N, Edwards K, Pritchard N, Mathur A, Mallen EA, Atchison DA. Biometry of eyes in type 1 diabetes. Biomed Opt Express. 2015;6(3):702-15
  10. Yuan D, Spaeth EB, Vernino S, Muppidi S. Disproportionate pupillary involvement in diabetic autonomic neuropathy. Clin Auton Res. 2014;24(6):305-9
  11. Smith SA, Smith SE. Reduced pupillary light refl ex in diabetic autonomic neuropathy. Diabetologia. 1983;24:330-2
  12. Straub RH, Thies U, Jeron A, et al. Valid parameters for investigation of the pupillary light refl ex in normal and diabetic subjects shown by factor analysis and partial correlation. Diabetologia. 1994;37:414-9
  13. Zeng H, Wani OM, Wasylczyk P, Kaczmarek R, Priimagi A. Self-Regulating Iris Based on Light-Actuated Liquid Crystal Elastomer. Adv Mater. 2017 Jun 7. doi:10.1002/adma.201701814. [Epub ahead of print] PubMed PMID: 28589679
  14. Bootsma S, Tahzib N, Eggink F, de Brabander J, Nuijts R. Comparison of two pupillometers in determining pupil size for refractive surgery. Acta Ophthalmol Scand. 2007;85(3):324-8
  15. Quisling S, Sjoberg S, Zimmerman B, Goins K, Sutphin J. Comparison of Pentacam and Orbscan IIz on posterior curvature topography measurement in keratoconus eyes. Ophthalmology. 2006;113:1629-32 16. Serdarogullari H, Tetikoglu M, Karahan H, Altin F, Elcioglu M. Prevalence of keratoco